BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28849413)

  • 21. Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy.
    Rusthoven CG; Lanning RM; Jones BL; Amini A; Koshy M; Sher DJ; Bowles DW; McDermott JD; Jimeno A; Karam SD
    Radiother Oncol; 2017 Jul; 124(1):139-146. PubMed ID: 28433411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.
    Siti-Azrin AH; Norsa'adah B; Naing NN
    BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of Ki-67 acts a poor prognosis indicator in locally advanced nasopharyngeal carcinoma.
    Zhao Y; Shen L; Huang X; Jing D; Huang D; Fu J; Li Z; Zhang G; Shen L
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):390-396. PubMed ID: 28947213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.
    Miao J; Xiao W; Wang L; Han F; Wu H; Deng X; Guo X; Zhao C
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1263-1273. PubMed ID: 28247035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of primary gross tumor volume and standardized uptake value of
    Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
    Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.
    Luo XL; Zhong GZ; Hu LY; Chen J; Liang Y; Chen QY; Liu Q; Rao HL; Chen KL; Cai QQ
    Oncotarget; 2015 Dec; 6(41):44037-48. PubMed ID: 26503474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of serum bilirubin in southern Chinese patients with advanced nasopharyngeal carcinoma.
    Yao JJ; Kou J; Peng QH; Dong J; Zhang WJ; Lawrence WR; Zhang F; Zhou GQ; Wang SY; Sun Y
    Clin Chim Acta; 2018 Sep; 484():314-319. PubMed ID: 29860034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
    Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
    Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: Analysis of 1230 patients with positive cervical nodal metastasis.
    Chen FP; Zhou GQ; Qi ZY; Lin L; Hu J; Wang XJ; Sun Y
    PLoS One; 2017; 12(5):e0176995. PubMed ID: 28489930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse status as a prognostic factor in patients receiving salvage surgery for recurrent or residual nasopharyngeal cancer after definitive treatment.
    Chee J; Ting Y; Ong YK; Chao SS; Loh KS; Lim CM
    Head Neck; 2016 Sep; 38(9):1393-400. PubMed ID: 27043448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
    Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
    Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
    Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
    Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prognostic model combining CD4/CD8 ratio and N stage predicts the risk of distant metastasis for patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy.
    Tao CJ; Chen YY; Jiang F; Feng XL; Jin QF; Jin T; Piao YF; Chen XZ
    Oncotarget; 2016 Jul; 7(29):46653-46661. PubMed ID: 27270307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 71 patients and analysis of the prognostic factors].
    Sun X; Liu J; Wang H; Yu H; Wang J; Li H; Gu Y; Guo L; Wang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Nov; 50(11):890-5. PubMed ID: 26887992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multivariate analysis of prognostic makers in patients with nasopharyngeal carcinoma intreatment of radiotherapy combined with induction chemotherapy].
    Liu J; Li S; Wang Y; Shi Y; Zhu L; Wu C
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):937-40. PubMed ID: 26596014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma.
    Toh CK; Heng D; Ong YK; Leong SS; Wee J; Tan EH
    Br J Cancer; 2005 Apr; 92(8):1382-7. PubMed ID: 15812546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Li AC; Xiao WW; Wang L; Shen GZ; Xu AA; Cao YQ; Huang SM; Lin CG; Han F; Deng XW; Zhao C
    Tumour Biol; 2015 Nov; 36(11):8349-57. PubMed ID: 26014515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
    Huang J; Fogg M; Wirth LJ; Daley H; Ritz J; Posner MR; Wang FC; Lorch JH
    Cancer; 2017 Jul; 123(14):2642-2650. PubMed ID: 28222215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.